nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2D6—Parkinson's disease	0.805	1	CbGaD
Rimonabant—CNR1—Signaling Pathways—MAG—Parkinson's disease	0.000236	0.00121	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—DRD3—Parkinson's disease	0.000235	0.0012	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000234	0.0012	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000234	0.0012	CbGpPWpGaD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000231	0.00119	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000229	0.00117	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000226	0.00116	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGF20—Parkinson's disease	0.000224	0.00115	CbGpPWpGaD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000223	0.00115	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000219	0.00113	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000219	0.00112	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000218	0.00112	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000218	0.00112	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EDN1—Parkinson's disease	0.000216	0.00111	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PDYN—Parkinson's disease	0.000216	0.00111	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—DRD2—Parkinson's disease	0.000212	0.00109	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HTR7—Parkinson's disease	0.000212	0.00109	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000209	0.00107	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000208	0.00107	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000206	0.00106	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GFAP—Parkinson's disease	0.000203	0.00104	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—INSR—Parkinson's disease	0.000201	0.00103	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GRM5—Parkinson's disease	0.000201	0.00103	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000201	0.00103	CbGpPWpGaD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000196	0.001	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGB—Parkinson's disease	0.00019	0.000973	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000189	0.000971	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HTR1A—Parkinson's disease	0.000189	0.000968	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000187	0.000959	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TAC1—Parkinson's disease	0.000186	0.000954	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000186	0.000953	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000184	0.000942	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—DRD1—Parkinson's disease	0.000182	0.000935	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000179	0.000918	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000178	0.000914	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—DRD3—Parkinson's disease	0.000177	0.000906	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGF20—Parkinson's disease	0.000176	0.000903	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000171	0.000876	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EDN1—Parkinson's disease	0.00017	0.000871	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000165	0.000846	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000164	0.00084	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000164	0.000839	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000162	0.000829	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000161	0.000826	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—DRD2—Parkinson's disease	0.00016	0.000819	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HTR7—Parkinson's disease	0.00016	0.000819	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000159	0.000818	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000159	0.000814	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—INSR—Parkinson's disease	0.000158	0.000808	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000151	0.000775	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000149	0.000765	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGB—Parkinson's disease	0.000149	0.000764	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000149	0.000762	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000148	0.00076	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000148	0.000758	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000147	0.000755	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TAC1—Parkinson's disease	0.000146	0.000748	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000146	0.000748	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000144	0.00074	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000143	0.000736	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DRD1—Parkinson's disease	0.000143	0.000734	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DRD3—Parkinson's disease	0.000139	0.000711	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000138	0.000709	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000136	0.000699	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000135	0.000694	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IGF2—Parkinson's disease	0.000134	0.000686	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IGF1R—Parkinson's disease	0.000129	0.000664	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000129	0.000664	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EDN1—Parkinson's disease	0.000128	0.000656	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000126	0.000648	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HTR7—Parkinson's disease	0.000125	0.000643	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DRD2—Parkinson's disease	0.000125	0.000643	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000125	0.000639	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000124	0.000634	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000123	0.000631	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000123	0.000629	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000123	0.000628	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000122	0.000626	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000122	0.000625	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000122	0.000624	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000121	0.000622	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000121	0.00062	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00012	0.000617	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NGF—Parkinson's disease	0.000117	0.000603	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000116	0.000593	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000113	0.00058	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000112	0.000575	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HTR2A—Parkinson's disease	0.000112	0.000574	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000111	0.000572	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000111	0.000567	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000107	0.000547	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000105	0.000539	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF2—Parkinson's disease	0.000105	0.000539	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000105	0.000537	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000105	0.000537	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000105	0.000537	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.000104	0.000535	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APOE—Parkinson's disease	0.000104	0.000533	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000104	0.000533	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000103	0.00053	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000103	0.000527	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000102	0.000521	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EDN1—Parkinson's disease	0.0001	0.000515	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.75e-05	0.0005	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.62e-05	0.000493	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	9.58e-05	0.000491	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	9.44e-05	0.000484	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NGF—Parkinson's disease	9.22e-05	0.000473	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—INS—Parkinson's disease	8.88e-05	0.000456	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HTR2A—Parkinson's disease	8.78e-05	0.00045	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.44e-05	0.000433	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APOE—Parkinson's disease	8.16e-05	0.000419	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.08e-05	0.000414	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.04e-05	0.000413	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.02e-05	0.000412	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ND3—Parkinson's disease	8.01e-05	0.000411	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.01e-05	0.000411	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.97e-05	0.000409	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ND3—Parkinson's disease	7.95e-05	0.000408	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MCCC1—Parkinson's disease	7.95e-05	0.000408	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.93e-05	0.000407	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.54e-05	0.000387	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—OMD—Parkinson's disease	7.54e-05	0.000387	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TALDO1—Parkinson's disease	7.47e-05	0.000383	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—OMD—Parkinson's disease	7.47e-05	0.000383	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.39e-05	0.000379	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.29e-05	0.000374	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.21e-05	0.00037	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.14e-05	0.000366	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	7.08e-05	0.000363	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—INS—Parkinson's disease	6.97e-05	0.000358	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.81e-05	0.00035	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ND3—Parkinson's disease	6.79e-05	0.000348	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MCCC1—Parkinson's disease	6.79e-05	0.000348	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCH1—Parkinson's disease	6.76e-05	0.000347	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP3—Parkinson's disease	6.61e-05	0.000339	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—Parkinson's disease	6.57e-05	0.000337	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TALDO1—Parkinson's disease	6.38e-05	0.000327	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—OMD—Parkinson's disease	6.38e-05	0.000327	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.09e-05	0.000313	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK8—Parkinson's disease	6.08e-05	0.000312	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GBA—Parkinson's disease	6.07e-05	0.000312	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.07e-05	0.000312	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DBH—Parkinson's disease	6.07e-05	0.000312	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	6.05e-05	0.00031	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FBP1—Parkinson's disease	6.02e-05	0.000309	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DBH—Parkinson's disease	6.02e-05	0.000309	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GBA—Parkinson's disease	6.02e-05	0.000309	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCH1—Parkinson's disease	5.77e-05	0.000296	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ND3—Parkinson's disease	5.24e-05	0.000269	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.24e-05	0.000269	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.21e-05	0.000267	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—Parkinson's disease	5.19e-05	0.000266	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—Parkinson's disease	5.16e-05	0.000264	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GBA—Parkinson's disease	5.15e-05	0.000264	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FBP1—Parkinson's disease	5.15e-05	0.000264	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DBH—Parkinson's disease	5.15e-05	0.000264	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.93e-05	0.000253	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—OMD—Parkinson's disease	4.93e-05	0.000253	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK8—Parkinson's disease	4.77e-05	0.000245	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.67e-05	0.00024	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DDC—Parkinson's disease	4.46e-05	0.000229	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.46e-05	0.000229	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DDC—Parkinson's disease	4.42e-05	0.000227	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.21e-05	0.000216	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTA4—Parkinson's disease	4.17e-05	0.000214	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.12e-05	0.000211	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DBH—Parkinson's disease	3.97e-05	0.000204	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.97e-05	0.000204	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GBA—Parkinson's disease	3.97e-05	0.000204	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—Parkinson's disease	3.88e-05	0.000199	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.79e-05	0.000194	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DDC—Parkinson's disease	3.78e-05	0.000194	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.76e-05	0.000193	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.75e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.72e-05	0.000191	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA4—Parkinson's disease	3.57e-05	0.000183	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.54e-05	0.000182	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.52e-05	0.000181	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	3.21e-05	0.000165	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MAOB—Parkinson's disease	3.18e-05	0.000163	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—Parkinson's disease	3.05e-05	0.000156	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.03e-05	0.000155	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DDC—Parkinson's disease	2.91e-05	0.00015	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.76e-05	0.000142	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.75e-05	0.000141	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.74e-05	0.00014	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.71e-05	0.000139	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.55e-05	0.000131	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.53e-05	0.00013	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.52e-05	0.000129	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.5e-05	0.000128	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TH—Parkinson's disease	2.49e-05	0.000128	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.48e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TH—Parkinson's disease	2.46e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.45e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.39e-05	0.000122	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.37e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.36e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.32e-05	0.000119	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.16e-05	0.000111	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.14e-05	0.00011	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—COMT—Parkinson's disease	2.11e-05	0.000108	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TH—Parkinson's disease	2.11e-05	0.000108	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.1e-05	0.000108	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.1e-05	0.000108	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—COMT—Parkinson's disease	2.1e-05	0.000107	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.09e-05	0.000107	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.08e-05	0.000107	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.07e-05	0.000106	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.06e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.02e-05	0.000104	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.99e-05	0.000102	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.97e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.93e-05	9.92e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.92e-05	9.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.85e-05	9.5e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.84e-05	9.41e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.82e-05	9.35e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—COMT—Parkinson's disease	1.79e-05	9.18e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.79e-05	9.18e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.78e-05	9.14e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.78e-05	9.12e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.76e-05	9.02e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.71e-05	8.76e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.69e-05	8.69e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.69e-05	8.65e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.67e-05	8.55e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.65e-05	8.46e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.64e-05	8.4e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TH—Parkinson's disease	1.63e-05	8.34e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOE—Parkinson's disease	1.59e-05	8.16e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOE—Parkinson's disease	1.58e-05	8.09e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.57e-05	8.04e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.56e-05	8e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.45e-05	7.42e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—COMT—Parkinson's disease	1.38e-05	7.09e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.38e-05	7.05e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.37e-05	7.04e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—INS—Parkinson's disease	1.36e-05	6.97e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.36e-05	6.96e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOE—Parkinson's disease	1.35e-05	6.91e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—INS—Parkinson's disease	1.35e-05	6.91e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.3e-05	6.68e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.26e-05	6.48e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.21e-05	6.21e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—INS—Parkinson's disease	1.15e-05	5.9e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.12e-05	5.73e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOE—Parkinson's disease	1.04e-05	5.33e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—INS—Parkinson's disease	8.88e-06	4.56e-05	CbGpPWpGaD
